Chapter 5

Valuation and Estimates

At $35.14, KBR trades at 8.9x its adjusted earnings and roughly 11.5% of its market value in annual free cash flow — a low-double-digit multiple that has compressed by about a third since late 2024 while earnings rose. The decline is almost entirely re-rating, not a downgrade to profit. The open question is whether 8.9x is a discount to fair value or a fair price for a slow-growing contractor whose recent profit was flattered by one joint venture.

Sources: price and consensus per market data as of July 17, 2026; free cash flow of $515M against a market capitalisation near $4.5B, from the FY2025 cash-flow statement [1].

The decline was a re-rating, not an earnings miss

KBR peaked at $72.02 on November 11, 2024, closed that year near $58, and now trades at $35.14 — down about 39% from the year-end level and 51% from the peak. Over the same window the business earned more, not less: adjusted EPS rose from $3.33 in FY2024 to $3.93 in FY2025 [2], and management guides $3.87 to $4.22 for FY2026 [3]. Held against a stable ~$3.9 earnings base, the multiple fell from roughly 15x at the end of 2024 to 8.9x today. The price move is the multiple moving, not the numerator.

Source: market price history, quarter-end closes; November 11, 2024 intraday-basis peak of $72.02 shown in text. As reported.

The de-rating did not reverse when the company announced its plan to spin off the government-services segment on September 24, 2025 (The MTS Spin-Off): the stock sat near $49 that day and drifted to $35 over the following ten months. Whatever value the separation is meant to surface, the market has not yet paid for it.

Sources: price change from quarter-end closes (market data); adjusted EPS $3.33 (FY2024) to $3.93 (FY2025) [4]. Multiples computed on the $3.93 FY2025 adjusted base at the two prices.

Three years of results, in one place

The record beneath the multiple is one of steady top-line growth, expanding adjusted profitability and cash that has run ahead of earnings. Revenue grew from $6.96 billion in FY2023 to $7.79 billion in FY2025; operating income rose from $449 million to $778 million; and adjusted EPS climbed from $2.91 to $3.93 [5][6]. The GAAP loss in FY2023 was a below-the-line convertible-notes charge, not an operating event (Company and Thesis); on cash the years are consistently positive, with free cash flow of $515 million in FY2025 covering adjusted net income (Earnings to Cash).

Sources: revenue, operating results and GAAP EPS from the FY2025 10-K [7]; adjusted EPS and adjusted EBITDA from earnings presentations [8][9]; free cash flow from the cash-flow statement [10]; FY2026 figures are guidance midpoints [11]. FY2026E free cash flow shown on an adjusted operating-cash-flow basis less modest capex.

What the forward numbers say

The forward setup is the counterweight to the cheap multiple: growth is decelerating to low single digits. Management's FY2026 guidance is revenue of $7.90–8.36 billion, adjusted EBITDA of $980–1,040 million and adjusted EPS of $3.87–4.22 — a midpoint about 3% above FY2025 — and it was reaffirmed at the Q1 FY2026 call in May 2026 [12][13]. Consensus sits inside that band at $3.96 for FY2026 and $4.13 for FY2027, with revenue of roughly $8.0 billion and $8.4 billion — implying adjusted EPS growth of about 1% and 4%.

Sources: adjusted EPS actuals from earnings presentations [14][15]; FY2026–27 figures are consensus estimates (market data). Management's FY2026 adjusted-EPS guidance band is $3.87–4.22.

Two features of the consensus matter for a value read. First, it barely moves: the FY2026 number has drifted down only fractionally over the past 90 days, and the balance of estimate revisions has been roughly even. Second, the analysts covering the stock are neutral-to-constructive rather than bearish — four buys, four holds and no sells — with the debate about the multiple, not the earnings. Neither the company nor the Street is forecasting a profit decline; the pessimism in the share price is about the durability and quality of the base, which the joint-venture concentration in FY2025 gives reason to question (New KBR Economics).

The multiple against its own cash and against peers

On every earnings-based measure KBR sits in the high-single-digit to low-double-digit range. Against roughly $4.5 billion of equity value and $2.1 billion of net debt — total debt of $2.60 billion against $0.50 billion of cash, an enterprise value near $6.6 billion [16] — the business trades at about 8.4x operating income and 6.8x adjusted EBITDA, falling toward 6.5x on the FY2026 guide.

Source: derived from reported FY2025 financials and market data. Enterprise value from net debt of $2.1B [17]; free cash flow of $515M [18]; shareholder returns of $329M buybacks plus $84M dividends [19].

A blended multiple obscures that KBR is two businesses with different peer sets. The government-services segment — the larger, and the piece departing in the spin — competes with a group that itself trades cheaply: Leidos and Booz Allen are near 9x trailing GAAP earnings and SAIC around 13x. The Sustainable Technology Solutions licensor's cleanest listed comparable, Technip Energies, trades closer to 16x. KBR's blended 8.9x adjusted multiple sits at or below where its government half is valued and well below its technology half — the arithmetic the separation is designed to exploit (The MTS Spin-Off).

Source: derived from each company's latest annual filing and market capitalisation (market data). GAAP trailing earnings; Jacobs and Amentum are omitted because their reported earnings are distorted by separation and merger accounting. Technip Energies reports in euros; the ratio is currency-neutral.

What the price implies

At $35.14 the market values KBR at roughly 8.9x forward earnings and 6.5x forward EBITDA — a level normally reserved for a business expected to shrink, whereas KBR and its analysts both forecast modest growth. The consensus mean price target is $46.57, about 33% above the current price, with a median of $45 and a range of $36 to $60; the mean target implies a multiple of roughly 11.8x the FY2026 estimate — a partial re-rating toward the government-services peer group, not a heroic one.

Source: consensus analyst price targets, market data as of July 17, 2026; even the lowest target of $36 sits above the current $35.14.

The read the evidence supports: KBR is priced conservatively — near the bottom of its own peer group and at a large discount to the analysts who follow it, while generating a double-digit free-cash-flow yield and returning about 9% of its market value each year in buybacks and dividends [20]. The company has $427 million left on its repurchase authorisation and has raised the dividend each year, from $0.54 in FY2023 to $0.66 in FY2025 [21][22].

The strongest fact against that read is that the FY2025 earnings base the multiple is measured on was inflated by a single item: a $134 million one-time favorable estimate change on the Plaquemines LNG joint venture, larger than the entire year-over-year rise in equity earnings, sitting inside the technology segment (New KBR Economics). On a base that strips the LNG catch-up, forward earnings power is lower and the multiple correspondingly less cheap. The repurchases also carry a timing cost — the FY2025 buybacks were executed at prices above today's $35, with the fourth-quarter tranche bought at an average of $42.70 [23], so the buyback has not yet compounded value at the de-rated price.

What would change the read in either direction is concrete and near-term. The FY2026 quarters will show whether the technology segment holds a mid-teens margin once the LNG contribution normalises; the spin-off Form 10, expected later in 2026, will disclose each successor's standalone earnings and debt; and a re-rating of the two pieces toward their separate peer multiples — rather than the blended 8.9x — is what turns a cheap-looking contractor into realised value. Absent those, 8.9x is defensible as a fair price for a low-growth, JV-flattered, net-debt-carrying business, not obviously a mispricing.